Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Allium ascalonicum L. extract may help improve insulin resistance.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

A balanced diet and healthy lifestyle help manage PCOS symptoms.

Two teenage boys lost hair after taking a drug for growth, which was not a known side effect for kids.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

People with male pattern baldness are more likely to have metabolic syndrome.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Bald men may have higher heart disease risk.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Baldness may indicate higher heart disease risk in men.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Hidden fungal infections might cause heart disease and clogged arteries.